{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T05:41:40Z","timestamp":1656999700061},"reference-count":43,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.3892\/or.2016.5005","type":"journal-article","created":{"date-parts":[[2016,8,5]],"date-time":"2016-08-05T06:21:56Z","timestamp":1470378116000},"page":"1927-1938","source":"Crossref","is-referenced-by-count":2,"title":["RUNX3 plays an important role in As2O3-induced apoptosis and allows cells to overcome MSC-mediated drug resistance"],"prefix":"10.3892","volume":"36","author":[{"given":"Guo-Zheng","family":"Pan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng-Xian","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Gang","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui-Fang","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang-Fu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-Jun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2016,8,5]]},"reference":[{"key":"key20180107221254_b1-or-36-04-1927","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1182\/blood-2010-02-269894","article-title":"Platelet-derived growth factor (PDGF)-PDGF receptor interaction activates bone marrow-derived mesenchymal stromal cells derived from chronic lymphocytic leukemia: implications for an angiogenic switch","volume":"116","author":"Ding","year":"2010","journal-title":"Blood"},{"key":"key20180107221254_b2-or-36-04-1927","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13046-015-0172-3","article-title":"Gastric cancer-derived mesenchymal stem cells prompt gastric cancer progression through secretion of interleukin-8","volume":"34","author":"Li","year":"2015","journal-title":"J Exp Clin Cancer Res"},{"key":"key20180107221254_b3-or-36-04-1927","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.cell.2004.07.004","article-title":"Tie2\/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche","volume":"118","author":"Arai","year":"2004","journal-title":"Cell"},{"key":"key20180107221254_b4-or-36-04-1927","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1007\/s00432-014-1723-2","article-title":"Gastric cancer-derived MSC-secreted PDGF-DD promotes gastric cancer progression","volume":"140","author":"Huang","year":"2014","journal-title":"J Cancer Res Clin Oncol"},{"key":"key20180107221254_b5-or-36-04-1927","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.3324\/haematol.2009.017178","article-title":"Bone marrow mesenchymal stromal cells non-selectively protect chronic myeloid leukemia cells from imatinib-induced apoptosis via the CXCR4\/CXCL12 axis","volume":"95","author":"Vianello","year":"2010","journal-title":"Haematologica"},{"key":"key20180107221254_b6-or-36-04-1927","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1586\/ehm.11.30","article-title":"The bone marrow microenvironment and leukemia: Biology and therapeutic targeting","volume":"4","author":"Sison","year":"2011","journal-title":"Expert Rev Hematol"},{"key":"key20180107221254_b7-or-36-04-1927","doi-asserted-by":"crossref","first-page":"e11716","DOI":"10.1371\/journal.pone.0011716","article-title":"Elucidating the CXCL12\/CXCR4 signaling network in chronic lymphocytic leukemia through phosphopro-teomics analysis","volume":"5","author":"O'Hayre","year":"2010","journal-title":"PLoS One"},{"key":"key20180107221254_b8-or-36-04-1927","doi-asserted-by":"crossref","first-page":"16228","DOI":"10.1038\/srep16228","article-title":"Improving chemotherapeutic efficiency in acute myeloid leukemia treatments by chemically synthesized peptide interfering with CXCR4\/CXCL12 axis","volume":"5","author":"Li","year":"2015","journal-title":"Sci Rep"},{"key":"key20180107221254_b9-or-36-04-1927","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4161\/cbt.26607","article-title":"Role of chemokines and their receptors in chronic lymphocytic leukemia: Function in microenvironment and targeted therapy","volume":"15","author":"Han","year":"2014","journal-title":"Cancer Biol Ther"},{"key":"key20180107221254_b10-or-36-04-1927","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1038\/sj.leu.2401602","article-title":"Overexpression of the chemokine receptor CXCR4 in B cell chronic lymphocytic leukemia is associated with increased functional response to stromal cell-derived factor-1 (SDF-1)","volume":"13","author":"M\u00f6hle","year":"1999","journal-title":"Leukemia"},{"key":"key20180107221254_b11-or-36-04-1927","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1007\/s00018-014-1830-x","article-title":"CXCL12\/CXCR4 axis in the pathogenesis of acute lymphoblastic leukemia (ALL): A possible therapeutic target","volume":"72","author":"de Lourdes Perim","year":"2015","journal-title":"Cell Mol Life Sci"},{"key":"key20180107221254_b12-or-36-04-1927","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1182\/blood-2006-07-035857","article-title":"Mechanisms of regulation of CXCR4\/SDF-1 (CXCL12)-dependent migration and homing in multiple myeloma","volume":"109","author":"Alsayed","year":"2007","journal-title":"Blood"},{"key":"key20180107221254_b13-or-36-04-1927","doi-asserted-by":"crossref","first-page":"6206","DOI":"10.1182\/blood-2008-06-162123","article-title":"Chemo-sensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100","volume":"113","author":"Nervi","year":"2009","journal-title":"Blood"},{"key":"key20180107221254_b14-or-36-04-1927","doi-asserted-by":"crossref","first-page":"8947","DOI":"10.18632\/oncotarget.2407","article-title":"Plerixafor as a chemosensitizing agent in pediatric acute lymphoblastic leukemia: efficacy and potential mechanisms of resistance to CXCR4 inhibition","volume":"5","author":"Sison","year":"2014","journal-title":"Oncotarget"},{"key":"key20180107221254_b15-or-36-04-1927","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s12032-015-0705-9","article-title":"Are there any new insights for G-CSF and\/or AMD3100 in chemotherapy of haematological malignants?","volume":"32","author":"Shen","year":"2015","journal-title":"Med Oncol"},{"key":"key20180107221254_b16-or-36-04-1927","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.18632\/oncotarget.6465","article-title":"Ulocuplumab (BMS-936564\/MDX1338): A fully human anti-CXCR4 antibody induces cell death in chronic lymphocytic leukemia mediated through a reactive oxygen species- dependent pathway","volume":"7","author":"Kashyap","year":"2016","journal-title":"Oncotarget"},{"key":"key20180107221254_b17-or-36-04-1927","doi-asserted-by":"crossref","first-page":"5549","DOI":"10.1182\/blood-2008-06-165068","article-title":"Isoform-selective phosphoinositide 3\u2032-kinase inhibitors inhibit CXCR4 signaling and overcome stromal cell-mediated drug resistance in chronic lymphocytic leukemia: A novel therapeutic approach","volume":"113","author":"Niedermeier","year":"2009","journal-title":"Blood"},{"key":"key20180107221254_b18-or-36-04-1927","first-page":"3297","article-title":"Consolidation therapy of arsenic trioxide alternated with chemotherapy achieves remarkable efficacy in newly diagnosed acute promyelocytic leukemia","volume":"8","author":"Liu","year":"2015","journal-title":"Onco Targets Ther"},{"key":"key20180107221254_b19-or-36-04-1927","doi-asserted-by":"crossref","first-page":"3852","DOI":"10.1200\/JCO.2001.19.18.3852","article-title":"United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia","volume":"19","author":"Soignet","year":"2001","journal-title":"J Clin Oncol"},{"key":"key20180107221254_b20-or-36-04-1927","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/sj.leu.2402106","article-title":"Studies on the clinical efficacy and pharmacokinetics of low-dose arsenic trioxide in the treatment of relapsed acute promyelocytic leukemia: A comparison with conventional dosage","volume":"15","author":"Shen","year":"2001","journal-title":"Leukemia"},{"key":"key20180107221254_b21-or-36-04-1927","doi-asserted-by":"crossref","first-page":"e0121912","DOI":"10.1371\/journal.pone.0121912","article-title":"Comparison of newly diagnosed and relapsed patients with acute promyelocytic leukemia treated with arsenic trioxide: Insight into mechanisms of resistance","volume":"10","author":"Chendamarai","year":"2015","journal-title":"PLoS One"},{"key":"key20180107221254_b22-or-36-04-1927","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/leu.2015.12","article-title":"Arsenic trioxide-based therapy of relapsed acute promyelocytic leukemia: Registry results from the European Leukemia Net","volume":"29","author":"Lengfelder","year":"2015","journal-title":"Leukemia"},{"key":"key20180107221254_b23-or-36-04-1927","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13148-014-0034-4","article-title":"Combining the differentiating effect of panobinostat with the apoptotic effect of arsenic trioxide leads to significant survival benefit in a model of t(8;21) acute myeloid leukemia","volume":"7","author":"Salmon","year":"2015","journal-title":"Clin Epigenetics"},{"key":"key20180107221254_b24-or-36-04-1927","doi-asserted-by":"crossref","first-page":"378","DOI":"10.18632\/genesandcancer.39","article-title":"STAT activation status differentiates leukemogenic from non-leukemogenic stem cells in AML and is suppressed by arsenic in t(6;9)-positive AML","volume":"5","author":"Oancea","year":"2014","journal-title":"Genes Cancer"},{"key":"key20180107221254_b25-or-36-04-1927","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.leukres.2004.01.011","article-title":"The potential of arsenic trioxide in the treatment of malignant disease: Past, present, and future","volume":"28","author":"Evens","year":"2004","journal-title":"Leuk Res"},{"key":"key20180107221254_b26-or-36-04-1927","first-page":"3345","article-title":"Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): I. As2O3 exerts dose-dependent dual effects on APL cells","volume":"89","author":"Chen","year":"1997","journal-title":"Blood"},{"key":"key20180107221254_b27-or-36-04-1927","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.molmed.2011.10.001","article-title":"Curing APL through PML\/RARA degradation by As2O3","volume":"18","author":"Lallemand-Breitenbach","year":"2012","journal-title":"Trends Mol Med"},{"key":"key20180107221254_b28-or-36-04-1927","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/sj.leu.2401650","article-title":"Arsenic trioxide-induced apoptosis and differentiation are associated respectively with mitochondrial transmembrane potential collapse and retinoic acid signaling pathways in acute promyelocytic leukemia","volume":"14","author":"Cai","year":"2000","journal-title":"Leukemia"},{"key":"key20180107221254_b29-or-36-04-1927","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s10495-008-0295-5","article-title":"Sodium selenite induces apoptosis by ROS-mediated endoplasmic reticulum stress and mitochondrial dysfunction in human acute promyelocytic leukemia NB4 cells","volume":"14","author":"Guan","year":"2009","journal-title":"Apoptosis"},{"key":"key20180107221254_b30-or-36-04-1927","doi-asserted-by":"crossref","first-page":"789","DOI":"10.18632\/oncoscience.242","article-title":"RUNX3 methylation and anti-tumor immunity","volume":"2","author":"Menheniott","year":"2015","journal-title":"Oncoscience"},{"key":"key20180107221254_b31-or-36-04-1927","doi-asserted-by":"crossref","first-page":"7743","DOI":"10.1158\/0008-5472.CAN-05-0743","article-title":"RUNX3, a novel tumor suppressor, is frequently inactivated in gastric cancer by protein mislocalization","volume":"65","author":"Ito","year":"2005","journal-title":"Cancer Res"},{"key":"key20180107221254_b32-or-36-04-1927","doi-asserted-by":"crossref","first-page":"4474","DOI":"10.1128\/MCB.01926-05","article-title":"The RUNX3 tumor suppressor upregulates Bim in gastric epithelial cells undergoing transforming growth factor beta-induced apoptosis","volume":"26","author":"Yano","year":"2006","journal-title":"Mol Cell Biol"},{"key":"key20180107221254_b33-or-36-04-1927","doi-asserted-by":"crossref","first-page":"8097","DOI":"10.1128\/MCB.25.18.8097-8107.2005","article-title":"RUNX3 suppresses gastric epithelial cell growth by inducing p21(WAF1\/Cip1) expression in cooperation with transforming growth factor {beta}-activated SMAD","volume":"25","author":"Chi","year":"2005","journal-title":"Mol Cell Biol"},{"key":"key20180107221254_b34-or-36-04-1927","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ccr.2008.08.004","article-title":"RUNX3 attenuates \u03b2-catenin\/T cell factors in intestinal tumorigenesis","volume":"14","author":"Ito","year":"2008","journal-title":"Cancer Cell"},{"key":"key20180107221254_b35-or-36-04-1927","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/jcp.21630","article-title":"Subnuclear targeting of the Runx3 tumor suppressor and its epigenetic association with mitotic chromosomes","volume":"218","author":"Pande","year":"2009","journal-title":"J Cell Physiol"},{"key":"key20180107221254_b36-or-36-04-1927","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/sj.onc.1205112","article-title":"The interaction of p53 with the nuclear matrix is mediated by F-actin and modulated by DNA damage","volume":"21","author":"Okorokov","year":"2002","journal-title":"Oncogene"},{"key":"key20180107221254_b37-or-36-04-1927","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0378-1119(95)00060-J","article-title":"Cloning, mapping and expression of PEBP2 alpha C, a third gene encoding the mammalian Runt domain","volume":"159","author":"Bae","year":"1995","journal-title":"Gene"},{"key":"key20180107221254_b38-or-36-04-1927","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/cmdc.201500497","article-title":"Small-molecule and peptide inhibitors of the pro-survival protein Mcl-1","volume":"11","author":"Beekman","year":"2016","journal-title":"Chem Med Chem"},{"key":"key20180107221254_b39-or-36-04-1927","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.pharmthera.2014.08.003","article-title":"Small molecule Mcl-1 inhibitors for the treatment of cancer","volume":"145","author":"Belmar","year":"2015","journal-title":"Pharmacol Ther"},{"key":"key20180107221254_b40-or-36-04-1927","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1101\/gad.1156903","article-title":"DNA damage response and MCL-1 destruction initiate apoptosis in adenovirus-infected cells","volume":"17","author":"Cuconati","year":"2003","journal-title":"Genes Dev"},{"key":"key20180107221254_b41-or-36-04-1927","first-page":"12","article-title":"Mcl-1 as a Therapeutic Target in Acute Myelogenous Leukemia (AML)","volume":"2","author":"Bose","year":"2013","journal-title":"Leuk Res Rep"},{"key":"key20180107221254_b42-or-36-04-1927","first-page":"101","article-title":"Myeloid cell leukemia-1 is associated with tumor progression by inhibiting apoptosis and enhancing angiogenesis in colorectal cancer","volume":"5","author":"Lee","year":"2014","journal-title":"Am J Cancer Res"},{"key":"key20180107221254_b43-or-36-04-1927","doi-asserted-by":"crossref","first-page":"35202","DOI":"10.18632\/oncotarget.6051","article-title":"MCL-1-independent mechanisms of synergy between dual PI3K\/mTOR and BCL-2 inhibition in diffuse large B cell lymphoma","volume":"6","author":"Lee","year":"2015","journal-title":"Oncotarget"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2016.5005\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T05:05:38Z","timestamp":1656997538000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2016.5005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,5]]},"references-count":43,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2016,8,5]]},"published-print":{"date-parts":[[2016,10]]}},"alternative-id":["10.3892\/or.2016.5005"],"URL":"https:\/\/doi.org\/10.3892\/or.2016.5005","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,5]]}}}